US4859672A
(en)
|
1986-10-29 |
1989-08-22 |
Rorer Pharmaceutical Corporation |
Pyrido[2,3-d]pyrimidinone and imidazo[4,5-b]pyrimidinone
|
JPS63199347A
(ja)
|
1987-02-14 |
1988-08-17 |
Konica Corp |
鮮鋭性の向上した高感度ハロゲン化銀写真感光材料
|
FR2643903A1
(fr)
|
1989-03-03 |
1990-09-07 |
Union Pharma Scient Appl |
Nouveaux derives de benzimidazole, leurs procedes de preparation, intermediaires de synthese, compositions pharmaceutiques les contenant, utiles notamment pour le traitement des maladies cardiovasculaires, et des ulceres duodenaux
|
GB9226879D0
(en)
|
1992-12-23 |
1993-02-17 |
Iaf Biochem Int |
Anti-viral compounds
|
US6444656B1
(en)
|
1992-12-23 |
2002-09-03 |
Biochem Pharma, Inc. |
Antiviral phosphonate nucleotides
|
CN1130363C
(zh)
|
1997-11-12 |
2003-12-10 |
三菱化学株式会社 |
嘌呤衍生物以及含有其作为有效成分的药物
|
ZA9810490B
(en)
|
1997-12-03 |
1999-05-20 |
Dainippon Pharmaceutical Co |
2-Aryl-8-oxodihydropurine derivative process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor
|
TW572758B
(en)
*
|
1997-12-22 |
2004-01-21 |
Sumitomo Pharma |
Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives
|
CZ27399A3
(cs)
|
1999-01-26 |
2000-08-16 |
Ústav Experimentální Botaniky Av Čr |
Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
|
JP3814125B2
(ja)
|
1999-06-02 |
2006-08-23 |
大日本住友製薬株式会社 |
2−アリール−8−オキソジヒドロプリン誘導体からなる医薬
|
CZ20022353A3
(cs)
|
2000-01-07 |
2003-02-12 |
Universitaire Instelling Antwerpen |
Deriváty purinu, způsob jejich přípravy a jejich použití
|
JP3675274B2
(ja)
|
2000-01-27 |
2005-07-27 |
ダイソー株式会社 |
9−(2−ヒドロキシアルキル)プリン誘導体および1−(2−ヒドロキシアルキル)ピリミジン誘導体の製造法
|
US20020128264A1
(en)
|
2000-07-07 |
2002-09-12 |
Taylor Eve M. |
Methods for treatment of conditions affected by activity of multidrug transporters
|
US20020040032A1
(en)
|
2000-07-07 |
2002-04-04 |
Glasky Michelle S. |
Methods for stimulation of synthesis of synaptophysin in the central nervous system
|
ATE499103T1
(de)
|
2000-07-07 |
2011-03-15 |
Spectrum Pharmaceuticals Inc |
Verfahren zur behandlung von arzneimittelinduzierter peripherer neuropathie und verwandten krankheitsformen
|
US20020040031A1
(en)
|
2000-07-07 |
2002-04-04 |
Glasky Michelle S. |
Methods for prevention of accumulation of amyloid beta peptide in the central nervous system
|
US20020091133A1
(en)
|
2000-12-12 |
2002-07-11 |
Eve M. Taylor |
Use of 9-substituted purine analogues and other molecules to stimulate neurogenesis
|
US20020156277A1
(en)
|
2001-04-20 |
2002-10-24 |
Fick David B. |
Synthesis and methods of use of purine analogues and derivatives
|
WO2003072757A2
(en)
|
2002-02-28 |
2003-09-04 |
Biota, Inc. |
Nucleotide mimics and their prodrugs
|
US7247621B2
(en)
|
2002-04-30 |
2007-07-24 |
Valeant Research & Development |
Antiviral phosphonate compounds and methods therefor
|
US7371857B2
(en)
|
2002-08-08 |
2008-05-13 |
Valeant Research & Development |
Synthesis for hydroxyalkylated heterocyclic bases
|
AU2003294249A1
(en)
|
2002-11-08 |
2004-06-03 |
Trimeris, Inc. |
Hetero-substituted benzimidazole compounds and antiviral uses thereof
|
JP2004217582A
(ja)
|
2003-01-16 |
2004-08-05 |
Abbott Japan Co Ltd |
9h−プリン誘導体
|
AU2004259736A1
(en)
|
2003-07-23 |
2005-02-03 |
Wyeth |
Sulfonyldihydroimid- azopyridinone compounds as 5-hydroxytryptamine-6 ligands
|
US20050054614A1
(en)
|
2003-08-14 |
2005-03-10 |
Diacovo Thomas G. |
Methods of inhibiting leukocyte accumulation
|
WO2005016348A1
(en)
|
2003-08-14 |
2005-02-24 |
Icos Corporation |
Method of inhibiting immune responses stimulated by an endogenous factor
|
CA2552664A1
(en)
|
2004-01-08 |
2005-07-28 |
Michigan State University |
Methods for treating and preventing hypertension and hypertension-related disorders
|
CA2730540A1
(en)
|
2004-05-13 |
2005-12-01 |
Vanderbilt University |
Phosphoinositide 3-kinase delta selective inhibitors for inhibiting angiogenesis
|
CA2567883A1
(en)
|
2004-05-25 |
2005-12-15 |
Icos Corporation |
Methods for treating and/or preventing aberrant proliferation of hematopoietic cells
|
EP1750715A1
(en)
|
2004-06-04 |
2007-02-14 |
Icos Corporation |
Methods for treating mast cell disorders
|
JP5048520B2
(ja)
|
2005-02-04 |
2012-10-17 |
ミレニアム ファーマシューティカルズ, インコーポレイテッド |
E1活性化酵素の阻害剤
|
EP1885356A2
(en)
|
2005-02-17 |
2008-02-13 |
Icos Corporation |
Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation
|
KR20080013886A
(ko)
|
2005-04-05 |
2008-02-13 |
파마코페이아, 인코포레이티드 |
면역억제용 퓨린 및 이미다조피리딘 유도체
|
US7884109B2
(en)
|
2005-04-05 |
2011-02-08 |
Wyeth Llc |
Purine and imidazopyridine derivatives for immunosuppression
|
US20090023723A1
(en)
|
2005-09-21 |
2009-01-22 |
Pharmacopeia Drug Discovery, Inc. |
Purinone derivatives for treating neurodegenerative diseases
|
US7989459B2
(en)
|
2006-02-17 |
2011-08-02 |
Pharmacopeia, Llc |
Purinones and 1H-imidazopyridinones as PKC-theta inhibitors
|
US7754463B2
(en)
|
2006-06-20 |
2010-07-13 |
Dana-Farber Cancer Institute |
Inhibitors of USP1 Deubiquitinating Enzyme Complex
|
US20100144738A1
(en)
|
2006-09-05 |
2010-06-10 |
William Bornmann |
Inhibitors of c-met and uses thereof
|
WO2008079460A2
(en)
*
|
2006-09-05 |
2008-07-03 |
Emory University |
Tyrosine kinase inhibitors for prevention or treatment of infection
|
WO2008045529A1
(en)
|
2006-10-12 |
2008-04-17 |
Serenex, Inc. |
Purine and pyrimidine derivatives for treatment of cancer and inflammatory diseases
|
BRPI0717773A2
(pt)
|
2006-10-19 |
2013-11-05 |
Signal Pharm Llc |
Composto, composição farmacêutica, e, métodos para tratar ou prevenir câncer, uma condição inflamatória, uma condição imunológica ou uma condição metabólica, e para inibir uma quinase em uma célula que expressa a dita quinase
|
US20080119496A1
(en)
|
2006-11-16 |
2008-05-22 |
Pharmacopeia Drug Discovery, Inc. |
7-Substituted Purine Derivatives for Immunosuppression
|
AU2006350748A1
(en)
|
2006-11-16 |
2008-05-22 |
Pharmacopeia, Llc |
7-substituted purine derivatives for immunosuppression
|
TW200902018A
(en)
*
|
2007-03-20 |
2009-01-16 |
Dainippon Sumitomo Pharma Co |
Novel adenine compound
|
WO2008118454A2
(en)
|
2007-03-23 |
2008-10-02 |
Amgen Inc. |
Derivatives of quinoline or benzopyrazine and their uses for the treatment of (inter alia) inflammatory diseases, autoimmune diseases or various kinds of cancer
|
WO2008117796A1
(ja)
|
2007-03-28 |
2008-10-02 |
Dainippon Sumitomo Pharma Co., Ltd. |
新規ムチリン誘導体
|
CA2682730A1
(en)
|
2007-04-11 |
2008-10-23 |
Alcon Research, Ltd. |
Use of an inhibitor of tnf.alpha. plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis
|
US20090182035A1
(en)
|
2007-04-11 |
2009-07-16 |
Alcon Research, Ltd. |
Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
|
WO2008131501A2
(en)
|
2007-04-27 |
2008-11-06 |
Katholieke Universiteit Leuven |
New anti-viral nucleoside analogs
|
GB0708258D0
(en)
|
2007-04-27 |
2007-06-06 |
Katholleke Universiteit Leuven |
New anti-viral nulceoside analogs
|
CA2686485A1
(en)
|
2007-05-23 |
2008-11-27 |
Pharmacopeia, Llc |
Purinones and 1h-imidazopyridinones as pkc-theta inhibitors
|
CN101687815A
(zh)
|
2007-06-26 |
2010-03-31 |
塞诺菲-安万特股份有限公司 |
苯并咪唑和氮杂苯并咪唑的区域选择性铜催化合成
|
JP2009007273A
(ja)
|
2007-06-27 |
2009-01-15 |
Ajinomoto Co Inc |
ジアミノピリミジン化合物の製造方法
|
US20090118301A1
(en)
|
2007-11-02 |
2009-05-07 |
Arbor Vita Corporation |
Compositions and Methods for Treating Cancer
|
WO2009062059A2
(en)
|
2007-11-08 |
2009-05-14 |
Pharmacopeia, Inc. |
Isomeric purinones and 1h-imidazopyridinones as pkc-theta inhibitors
|
CA2705834A1
(en)
|
2007-11-20 |
2009-05-28 |
Merck Sharp & Dohme Corp. |
Pyridinone non-nucleoside reverse transcriptase inhibitors
|
CA2722308C
(en)
|
2008-04-15 |
2024-02-27 |
Rfs Pharma, Llc. |
Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
|
CA2736522C
(en)
|
2008-09-09 |
2016-09-13 |
Boehringer Ingelheim International Gmbh |
Aza-benzimidazolone chymase inhibitors
|
WO2010036380A1
(en)
|
2008-09-26 |
2010-04-01 |
Intellikine, Inc. |
Heterocyclic kinase inhibitors
|
KR101675614B1
(ko)
|
2009-10-29 |
2016-11-11 |
벡투라 리미티드 |
Jak3 키나아제 저해제로서의 n―함유 헤테로아릴 유도체
|
JP2011136925A
(ja)
|
2009-12-28 |
2011-07-14 |
Dainippon Sumitomo Pharma Co Ltd |
含窒素二環性化合物
|
CN102821767A
(zh)
|
2010-02-03 |
2012-12-12 |
西格诺药品有限公司 |
Lkb1突变作为对tor激酶抑制剂的敏感性的预测生物标记的鉴定
|
US9518032B2
(en)
|
2010-04-30 |
2016-12-13 |
Dana-Farber Cancer Institute, Inc. |
Small molecule inhibitors of USP1 deubiquitinating enzyme activity
|
WO2011156889A1
(en)
|
2010-06-14 |
2011-12-22 |
Trt Pharma Inc. |
Novel modulators of nrf2 and uses thereof
|
EP2397482A1
(en)
|
2010-06-15 |
2011-12-21 |
Almirall, S.A. |
Heteroaryl imidazolone derivatives as jak inhibitors
|
JP2012012332A
(ja)
|
2010-06-30 |
2012-01-19 |
Dainippon Sumitomo Pharma Co Ltd |
新規アザインドール誘導体
|
WO2012003576A1
(en)
|
2010-07-06 |
2012-01-12 |
Université de Montréal |
Imidazopyridine, imidazopyrimidine and imidazopyrazine derivatives as melanocortin-4 receptor modulators
|
WO2012009258A2
(en)
|
2010-07-13 |
2012-01-19 |
Edward Roberts |
Peptidomimetic galanin receptor modulators
|
DE102010040233A1
(de)
|
2010-09-03 |
2012-03-08 |
Bayer Schering Pharma Aktiengesellschaft |
Bicyclische Aza-Heterocyclen und ihre Verwendung
|
TWI541241B
(zh)
|
2010-12-16 |
2016-07-11 |
健生科學愛爾蘭無限公司 |
作為呼吸道融合病毒抗病毒劑之咪唑并吡啶類
|
TWI527814B
(zh)
|
2010-12-16 |
2016-04-01 |
健生科學愛爾蘭無限公司 |
作為呼吸道融合病毒抗病毒劑之氮雜苯并咪唑類
|
TWI515187B
(zh)
|
2010-12-16 |
2016-01-01 |
健生科學愛爾蘭無限公司 |
作為呼吸道融合病毒抗病毒劑之吲哚類
|
TWI501967B
(zh)
|
2010-12-16 |
2015-10-01 |
Janssen R&D Ireland |
作為呼吸道融合病毒抗病毒劑之氮雜吲哚類
|
WO2012102405A1
(ja)
|
2011-01-28 |
2012-08-02 |
佐藤製薬株式会社 |
縮環化合物
|
US20140005164A1
(en)
|
2011-04-04 |
2014-01-02 |
Siena Biotech S.P.A. |
Wnt pathway antagonists
|
WO2013025628A1
(en)
|
2011-08-15 |
2013-02-21 |
Ligand Pharmaceuticals Incorporated |
Janus kinase inhibitor compounds and methods
|
WO2013033899A1
(en)
|
2011-09-08 |
2013-03-14 |
Merck Sharp & Dohme Corp. |
Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
|
BR112014009755B1
(pt)
|
2011-10-19 |
2022-09-13 |
Signal Pharmaceuticals, Llc |
Tratamento de câncer com inibidores de quinase tor
|
US8501724B1
(en)
|
2012-01-31 |
2013-08-06 |
Pharmacyclics, Inc. |
Purinone compounds as kinase inhibitors
|
BR112014020786A2
(pt)
|
2012-02-24 |
2020-10-27 |
Signal Pharmaceuticals, Llc |
método para tratamento de câncer de pulmão, método para alcançar um critério de avaliação de resposta em tumores sólidos, método para aumento da sobrevivência
|
US9340549B2
(en)
|
2012-03-05 |
2016-05-17 |
Amgen Inc. |
Oxazolidinone compounds and derivatives thereof
|
US9338896B2
(en)
|
2012-07-25 |
2016-05-10 |
Enthone, Inc. |
Adhesion promotion in printed circuit boards
|
US20150246888A1
(en)
|
2012-09-11 |
2015-09-03 |
Michael Johnson |
Enoyl reductase inhibitors with antibacterial activity
|
AU2013202768B2
(en)
*
|
2012-10-18 |
2015-11-05 |
Signal Pharmaceuticals, Llc |
Treatment of cancer with TOR kinase inhibitors
|
CA2896731A1
(en)
*
|
2012-12-28 |
2014-07-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inhibitors of the usp1/uaf1 deubiquitinase complex and uses thereof
|
JP6024979B2
(ja)
|
2013-02-21 |
2016-11-16 |
学校法人金沢工業大学 |
難燃組成物、それを用いた難燃化処理方法および難燃材料
|
US20160008356A1
(en)
|
2013-02-28 |
2016-01-14 |
Signal Pharmaceuticals, Llc |
Treatment of cancer with tor kinase inhibitors
|
US9187454B2
(en)
|
2013-03-13 |
2015-11-17 |
Boston Biomedical, Inc. |
Inhibitors of kinases and cancer stem cells, and methods of preparation and use thereof
|
CA2901334A1
(en)
|
2013-03-13 |
2014-10-02 |
Abbvie Inc. |
Pyridine cdk9 kinase inhibitors
|
CN109939113B
(zh)
|
2013-06-21 |
2022-02-15 |
恒翼生物医药科技(上海)有限公司 |
双环溴结构域抑制剂
|
MX2021001186A
(es)
|
2015-11-20 |
2022-10-11 |
Forma Therapeutics Inc |
Purinonas como inhibidores de proteasa especifica de ubiquitina 1.
|